Меню
Идёт набор NCT06596824

Personalized Digital Training Intervention to Reduce Inflammation by Correcting Pathological Movement Patterns in Pre-stage Knee Osteoarthritis After Anterior Cruciate Ligament Reconstruction

Без фазы С лечением Osteoarthritis (OA) of the Knee ACL Reconstruction

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Training intervention.
Кому может быть актуально
Состояния в реестре: Osteoarthritis (OA) of the Knee, ACL Reconstruction. Базовые параметры: 18 лет — 50 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Германия
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Не всё понятно в терминах? Прочитайте наш гид для пациентов →

Официальное название

Personalized Digital Training Intervention to Reduce Inflammation by Correcting Pathological Movement Patterns in Pre-stage Knee Osteoarthritis (OA)

Обзор

Osteoarthritis (OA) is a condition that causes pain and stiffness in the joints, often due to injuries like torn ligaments. Even after surgery, these injuries can lead to long-term joint problems. Current treatments don\'t fully prevent OA from developing. This study is testing a new 12-week exercise program designed to improve how the knee moves, using a special sensor-based system. The goal is to reduce joint inflammation and prevent the development of OA in patients who have had knee surgery.

Вмешательства

  • Поведенческое Training intervention
    Personalized digital training intervention aims to correct pathological knee movement and loading patterns and reduce inflammation in pre-stage knee osteoarthritis.

Первичные конечные точки

  • Primary Endpoint [Срок оценки: at 6-month follow-up visit]
Вторичные конечные точки (7)
  • Secondary Endpoint: Cartilage Thickness [Срок оценки: Baseline, 6, and 36 months follow-up visits]
  • Secondary Endpoint: Cartilage Volume [Срок оценки: Baseline, 6, and 36 months follow-up visits]
  • Secondary Endpoint: Cartilage Composition [Срок оценки: Baseline, 6, and 36 months follow-up visits]
  • Secondary Endpoint: Meniscus Position [Срок оценки: Baseline, 6, and 36 months follow-up visits]
  • Secondary Endpoint: Hoffa Synovitis [Срок оценки: Baseline, 6, and 36 months follow-up visits]
  • Secondary Endpoint: Effusion Synovitis [Срок оценки: Baseline, 6, and 36 months follow-up visits]
  • Secondary Endpoint: Magnetic Resonance Imaging Osteoarthritis Knee Score (MOAKS) [Срок оценки: Baseline, 6, and 36 months follow-up visits]

Критерии участия

Критерии включения

  • Signed written informed consent
  • Adult subjects between 18 to 50 years old at the time of screening
  • Primary ACL reconstruction within a maximum of 6 months after a unilateral ACL injury
  • Complete baseline assessment between 8 and 12 weeks after ACL reconstruction

Критерии исключения

  • Significant trauma to a weight-bearing joint within 12 months prior to study initiation (excluding the ACL injury)
  • Previous surgeries on the study knee (except for the ACL reconstruction)
  • Signs of knee OA as defined by the OARSI-Joint Space Narrowing (JSN) Score of two or more (standing AP x-ray)
  • Physical activity level: Tegner activity score before injury of 0-2 (very low activity) or 8-10 (very high activity)
  • Body mass index ≥ 30 kg/m2;
  • Inflammatory arthropathies;
  • Immunosuppression due to illness or medication;
  • Sepsis or hemostasis disorders;
  • Severe uncontrolled inflammatory disease or autoimmune disease (e.g., ulcerative colitis, Crohn's disease, etc.);
  • Having malignancy and undergoing treatment including chemotherapy, radiotherapy, or immunotherapy;
  • Contraindications for MRI, including pacemakers, defibrillators, metal implants, pregnancy, sensorineural hearing loss above 30 dB, tinnitus and claustrophobia
  • Unable to freely give their informed consent (e.g., individuals under legal guardianship).
  • Currently enrolled in or has not yet completed a period of at least 5 times as the half-life time of the drug used in the previous trial since ending other investigational device or drug trial(s)
  • Patients who are dependent on the sponsor, investigator, or study site;
  • Pregnant or breast-feeding women or women of childbearing potential not protected by an effective contraceptive method of birth control (defined as pearl index < 1);
  • Any form of substance abuse, psychiatric disorder, or other condition that, in the opinion of the Investigator, may invalidate communication with the Investigator and/or designated study personnel;
  • Patients who are committed to an institution by virtue of an order issued by either the judicial or the administrative authorities;

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Открытое
Основная цель
Профилактика

Центры проведения

Германия · 2 центра
  • Charité - Universitätsmedizin Berlin, BeMoveD - Berlin Movement Diagnostics — Berlin
  • Charité - Universitätsmedizin Berlin — Berlin

Идентификаторы

NCT: NCT06596824 · PROTO-WP4 · 101095635

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗